Advanced Biomed (ADVB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.98, -18.44% vs the prior close of $4.88.
- Volume 28.11K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ADVB slides 18.4% to $3.98, a 3-month low, 8 down days in a row. Closed at $3.98, -18.44% vs the prior close of $4.88. Day range $3.69β$4.69, opened at $4.69.
ADVB daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β ADVB slides 18.4% to $3.98, a 3-month low, 8 down days in a row
- Closed at $3.98, -18.44% vs the prior close of $4.88. Day range $3.69β$4.69, opened at $4.69.
- Volume was 28.11K shares, 0.2x its 50-day average of 129.84K β lighter than usual.
- Price is -46.9% vs its 50-day average ($7.49) and -34.7% vs its 200-day average ($6.10).
- 52-week range $3.61β$24.23; today's close sits at 2% of that range, 83.6% below the 52-week high.
- That makes 8 straight losses.
Oct 15, 2026 β ADVB slides 5.1% to $4.88, a 3-month low, 7 down days in a row
- Closed at $4.88, -5.06% vs the prior close of $5.14. Day range $4.88β$5.14, opened at $5.11.
- Volume was 10.70K shares, 0.1x its 50-day average of 135.45K β lighter than usual.
- Price is -35.4% vs its 50-day average ($7.56) and -20.2% vs its 200-day average ($6.11).
- 52-week range $3.61β$24.23; today's close sits at 6% of that range, 79.9% below the 52-week high.
- That makes 7 straight losses.
Oct 14, 2026 β ADVB dips 0.4% to $5.14, a 1-month low, 6 down days in a row
- Closed at $5.14, -0.39% vs the prior close of $5.16. Day range $5.14β$5.55, opened at $5.26.
- Volume was 13.70K shares, 0.1x its 50-day average of 136.89K β lighter than usual.
- Price is -32.5% vs its 50-day average ($7.62) and -16.0% vs its 200-day average ($6.12).
- 52-week range $3.61β$24.23; today's close sits at 7% of that range, 78.8% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 β ADVB dips 2.2% to $5.16, a 1-month low, 5 down days in a row
- Closed at $5.16, -2.18% vs the prior close of $5.28. Day range $5.01β$5.30, opened at $5.29.
- Volume was 4.80K shares, 0.0x its 50-day average of 138.05K β lighter than usual.
- Price is -32.8% vs its 50-day average ($7.68) and -15.9% vs its 200-day average ($6.13).
- 52-week range $3.61β$24.23; today's close sits at 8% of that range, 78.7% below the 52-week high.
- That makes 5 straight losses.
- SEC filings that day: 10-K.
Oct 12, 2026 β ADVB dips 0.7% to $5.28, a 1-month low, 4 down days in a row
- Closed at $5.28, -0.66% vs the prior close of $5.31. Day range $5.18β$5.51, opened at $5.51.
- Volume was 22.30K shares, 0.2x its 50-day average of 139.65K β lighter than usual.
- Price is -31.7% vs its 50-day average ($7.73) and -14.2% vs its 200-day average ($6.14).
- 52-week range $3.61β$24.23; today's close sits at 8% of that range, 78.2% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 β ADVB slides 13.2% to $5.31, a 1-month low, 3 down days in a row
- Closed at $5.31, -13.24% vs the prior close of $6.12. Day range $5.31β$6.07, opened at $6.07.
- Volume was 8.80K shares, 0.1x its 50-day average of 142.42K β lighter than usual.
- Price is -31.7% vs its 50-day average ($7.78) and -13.7% vs its 200-day average ($6.16).
- 52-week range $3.61β$24.23; today's close sits at 8% of that range, 78.1% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 β ADVB dips 1.4% to $6.12, a 1-month low
- Closed at $6.12, -1.45% vs the prior close of $6.21. Day range $6.10β$6.33, opened at $6.24.
- Volume was 21.60K shares, 0.1x its 50-day average of 144.68K β lighter than usual.
- Price is -22.3% vs its 50-day average ($7.88) and -0.7% vs its 200-day average ($6.17).
- 52-week range $3.61β$24.23; today's close sits at 12% of that range, 74.7% below the 52-week high.
Oct 7, 2026 β ADVB dips 2.7% to $6.21, a 1-month low
- Closed at $6.21, -2.66% vs the prior close of $6.38. Day range $6.14β$6.61, opened at $6.57.
- Volume was 22.40K shares, 0.2x its 50-day average of 149.23K β lighter than usual.
- Price is -22.1% vs its 50-day average ($7.97) and +0.6% vs its 200-day average ($6.17).
- 52-week range $3.61β$24.23; today's close sits at 13% of that range, 74.4% below the 52-week high.
Oct 6, 2026 β ADVB rises 0.6% to $6.38
- Closed at $6.38, +0.63% vs the prior close of $6.34. Day range $6.38β$6.74, opened at $6.39.
- Volume was 15.40K shares, 0.1x its 50-day average of 157.87K β lighter than usual.
- Price is -20.9% vs its 50-day average ($8.07) and +3.3% vs its 200-day average ($6.17).
- 52-week range $3.61β$24.23; today's close sits at 13% of that range, 73.7% below the 52-week high.
Oct 5, 2026 β ADVB slides 5.8% to $6.34
- Closed at $6.34, -5.79% vs the prior close of $6.73. Day range $6.34β$7.03, opened at $6.60.
- Volume was 15.00K shares, 0.1x its 50-day average of 252.10K β lighter than usual.
- Price is -22.9% vs its 50-day average ($8.23) and +2.6% vs its 200-day average ($6.18).
- 52-week range $3.61β$24.23; today's close sits at 13% of that range, 73.8% below the 52-week high.
Oct 2, 2026 β ADVB dips 2.6% to $6.73
- Closed at $6.73, -2.60% vs the prior close of $6.91. Day range $6.50β$7.05, opened at $6.97.
- Volume was 27.10K shares, 0.1x its 50-day average of 491.13K β lighter than usual.
- Price is -20.6% vs its 50-day average ($8.48) and +8.8% vs its 200-day average ($6.19).
- 52-week range $3.61β$24.23; today's close sits at 15% of that range, 72.2% below the 52-week high.
ADVB latest news & SEC filings
Every SEC filing by or about ADVB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 Β· Form 10-K β Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $127.64K
- Net income: $6.68M (prior year -$3.26M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $5.33 (prior year -$3.18) (swung to profit vs Jun 30, 2025)
Sep 28, 2026 Β· Form NT 10-K β Notice of late annual report
Notice of late annual report
Sep 22, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 20, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 20, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 20, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 17, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.02 β Ended a material agreement.
Jul 1, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
Jun 30, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
Things to know before you trade ADVB
- How much it moves: over the last 20 sessions the average daily move was 4.08% (largest 18.4%). That is a volatile stock.
- Liquidity: about 17.66K shares (β$70.27K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.98 vs a range of $3.61β$24.23 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Feb 20, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-K Oct 13, 2026; 8-K Jul 17, 2026; 8-K Jul 1, 2026.
- Share count: 1.65M shares outstanding (Oct 13, 2026), -92.4% vs a year earlier β the company has been reducing its share count.
- Listing: Nasdaq Β· industry: Services-Medical Laboratories.
ADVB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.69 | 4.69 | 3.69 | 3.98 | 28.11K |
| Oct 15, 2026 | 5.11 | 5.14 | 4.88 | 4.88 | 10.70K |
| Oct 14, 2026 | 5.26 | 5.55 | 5.14 | 5.14 | 13.70K |
| Oct 13, 2026 | 5.29 | 5.30 | 5.01 | 5.16 | 4.80K |
| Oct 12, 2026 | 5.51 | 5.51 | 5.18 | 5.28 | 22.30K |
| Oct 9, 2026 | 6.07 | 6.07 | 5.31 | 5.31 | 8.80K |
| Oct 8, 2026 | 6.24 | 6.33 | 6.10 | 6.12 | 21.60K |
| Oct 7, 2026 | 6.57 | 6.61 | 6.14 | 6.21 | 22.40K |
| Oct 6, 2026 | 6.39 | 6.74 | 6.38 | 6.38 | 15.40K |
| Oct 5, 2026 | 6.60 | 7.03 | 6.34 | 6.34 | 15.00K |
| Oct 2, 2026 | 6.97 | 7.05 | 6.50 | 6.73 | 27.10K |
| Oct 1, 2026 | 6.24 | 7.12 | 6.24 | 6.91 | 20.10K |
| Sep 30, 2026 | 6.37 | 6.48 | 6.23 | 6.23 | 14.90K |
| Sep 29, 2026 | 6.62 | 6.74 | 6.31 | 6.32 | 19.50K |
| Sep 28, 2026 | 6.67 | 7.23 | 6.59 | 6.73 | 43.20K |
| Sep 25, 2026 | 6.31 | 6.68 | 6.31 | 6.38 | 12.30K |
| Sep 24, 2026 | 6.35 | 6.54 | 6.31 | 6.31 | 8.90K |
| Sep 23, 2026 | 6.41 | 6.70 | 6.31 | 6.32 | 12.40K |
| Sep 22, 2026 | 6.53 | 6.77 | 6.38 | 6.38 | 12.20K |
| Sep 21, 2026 | 6.61 | 6.69 | 6.28 | 6.47 | 19.70K |
About Advanced Biomed
Advanced Biomed (ADVB) is listed on the Nasdaq and classified by the SEC under βServices-Medical Laboratoriesβ. Its business address is in RENO, NV. State of incorporation: NV. Fiscal year ends June 30. SEC CIK 1941029.
ADVB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ADVB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $127.64K | $6.68M | 5.33 | $-1.95M |
| Jun 30, 2025 | β | $-3.26M | -3.18 | $-5.83M |
| Jun 30, 2024 | β | $-2.78M | -0.14 | $-2.13M |
Latest balance sheet: total assets $13.75M, total liabilities $1.47M, cash $β (as of Jun 30, 2026).
ADVB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ADVB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.